Moreover, the AOSD synovial samples revealed a hyper-expression of IL-1, IL-6, and TNF, as well as their respective receptors, further reinforcing the rationale of targeting these cytokines through therapies. This evidence concerns the gene TNF and adult-onset Still disease.